Table of Contents China Tuberculosis Drugs Market Report 2012-2023 1 Tuberculosis Drugs Overview 1.1 Product Overview and Scope of Tuberculosis Drugs 1.2 Classification of Tuberculosis Drugs by Product Category 1.2.1 China Tuberculosis Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 China Tuberculosis Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 First-line Anti-TB Drugs 1.2.4 Second-line Anti-TB Drugs 1.3 China Tuberculosis Drugs Market by Application/End Users 1.3.1 China Tuberculosis Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 New Patients 1.3.3 Drug Resistant TB Patients 1.4 China Tuberculosis Drugs Market by Region 1.4.1 China Tuberculosis Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 South China Status and Prospect (2012-2023) 1.4.3 East China Status and Prospect (2012-2023) 1.4.4 Southwest China Status and Prospect (2012-2023) 1.4.5 Northeast China Status and Prospect (2012-2023) 1.4.6 North China Status and Prospect (2012-2023) 1.4.7 Central China Status and Prospect (2012-2023) 1.4.8 Northwest China Status and Prospect (2012-2023) 1.5 China Sales and Revenue ofSales and Revenue of Tuberculosis Drugs (2012-2023) 1.5.1 China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Tuberculosis Drugs 2.2 Raw Material Analysis of Tuberculosis Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Tuberculosis Drugs 2.4 Other Costs Analysis of Tuberculosis Drugs 2.5 Manufacturing Cost Structure Analysis of Tuberculosis Drugs 2.6 Manufacturing Process Analysis of Tuberculosis Drugs 2.7 Raw Materials Sources of Tuberculosis Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 China Tuberculosis Drugs Players/Suppliers Profiles and Sales Data 3.1 Sanofi 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Tuberculosis Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Sanofi Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Sanofi Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Sanofi Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.2 Pfizer 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Tuberculosis Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Pfizer Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Pfizer Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Pfizer Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.3 Janssen Products 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Tuberculosis Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Janssen Products Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Janssen Products Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Janssen Products Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.4 Otsuka 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Tuberculosis Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Otsuka Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Otsuka Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Otsuka Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.5 AstraZeneca 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Tuberculosis Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 AstraZeneca Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 AstraZeneca Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 AstraZeneca Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.6 Lupin Pharmaceuticals 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Tuberculosis Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Lupin Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Lupin Pharmaceuticals Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Lupin Pharmaceuticals Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.7 Akorn 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Tuberculosis Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Akorn Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Akorn Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Akorn Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.8 STI Pharma 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Tuberculosis Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 STI Pharma Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 STI Pharma Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 STI Pharma Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.9 Sandoz 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Tuberculosis Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sandoz Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sandoz Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Sandoz Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.10 Labatec Pharma SA 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Tuberculosis Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Labatec Pharma SA Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Labatec Pharma SA Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Labatec Pharma SA Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.11 Archivel Farma 3.12 BioMerieux 3.13 Cepheid 3.14 Epistem 4 China Tuberculosis Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 China Tuberculosis Drugs Market Competition by Players/Manufacturers 4.1.1 China Tuberculosis Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 China Tuberculosis Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 China Tuberculosis Drugs Sales and Revenue by Type 4.2.1 China Tuberculosis Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 China Tuberculosis Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 China Tuberculosis Drugs Sales and Revenue by Application 4.3.1 China Tuberculosis Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 China Tuberculosis Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 China Tuberculosis Drugs Sales (K Units) by Application 5 South China Tuberculosis Drugs (Sales, Revenue and Price) 5.1 South China Tuberculosis Drugs Sales and Value (2012-2017) 5.1.1 South China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 South China Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 5.1.3 South China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 South China Tuberculosis Drugs Sales (K Units) and Market Share by Type 5.3 South China Tuberculosis Drugs Sales (K Units) and Market Share by Application 6 East China Tuberculosis Drugs (Sales, Revenue and Price) 6.1 East China Tuberculosis Drugs Sales and Value (2012-2017) 6.1.1 East China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 East China Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 6.1.3 East China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 East China Tuberculosis Drugs Sales (K Units) and Market Share by Type 6.3 East China Tuberculosis Drugs Sales (K Units) and Market Share by Application 7 Southwest China Tuberculosis Drugs (Sales, Revenue and Price) 7.1 Southwest China Tuberculosis Drugs Sales and Value (2012-2017) 7.1.1 Southwest China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 Southwest China Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 7.1.3 Southwest China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 Southwest China Tuberculosis Drugs Sales (K Units) and Market Share by Type 7.3 Southwest China Tuberculosis Drugs Sales (K Units) and Market Share by Application 8 Northeast China Tuberculosis Drugs (Sales, Revenue and Price) 8.1 Northeast China Tuberculosis Drugs Sales and Value (2012-2017) 8.1.1 Northeast China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Northeast China Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Northeast China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Northeast China Tuberculosis Drugs Sales (K Units) and Market Share by Type 8.3 Northeast China Tuberculosis Drugs Sales (K Units) and Market Share by Application 9 North China Tuberculosis Drugs (Sales, Revenue and Price) 9.1 North China Tuberculosis Drugs Sales and Value (2012-2017) 9.1.1 North China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 North China Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 9.1.3 North China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 North China Tuberculosis Drugs Sales (K Units) and Market Share by Type 9.3 North China Tuberculosis Drugs Sales (K Units) and Market Share by Application 10 Central China Tuberculosis Drugs (Sales, Revenue and Price) 10.1 Central China Tuberculosis Drugs Sales and Value (2012-2017) 10.1.1 Central China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Central China Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Central China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Central China Tuberculosis Drugs Sales (K Units) and Market Share by Type 10.3 Central China Tuberculosis Drugs Sales (K Units) and Market Share by Application 11 Northwest China Tuberculosis Drugs (Sales, Revenue and Price) 11.1 Northwest China Tuberculosis Drugs Sales and Value (2012-2017) 11.1.1 Northwest China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Northwest China Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Northwest China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Northwest China Tuberculosis Drugs Sales (K Units) and Market Share by Type 11.3 Northwest China Tuberculosis Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 China Tuberculosis Drugs Market Forecast (2018-2023) 13.1 China Tuberculosis Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 China Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 China Tuberculosis Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 China Tuberculosis Drugs Price and Trend Forecast (2018-2023) 13.2 China Tuberculosis Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 China Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 China Tuberculosis Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 South China Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 East China Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Southwest China Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Northeast China Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 Southwest China Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Central China Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Northwest China Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 China Tuberculosis Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 China Tuberculosis Drugs Sales Forecast by Type (2018-2023) 13.3.2 China Tuberculosis Drugs Revenue Forecast by Type (2018-2023) 13.3.3 China Tuberculosis Drugs Price Forecast by Type (2018-2023) 13.4 China Tuberculosis Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure China Market Size (Million USD) Comparison 2012-2023 Table China Market Tuberculosis Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table China Tuberculosis Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table China Tuberculosis Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Tuberculosis Drugs Table China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure China Tuberculosis Drugs Sales (K Units) Market Share by Types in 2017 Figure First-line Anti-TB Drugs Picture Figure Second-line Anti-TB Drugs Picture Table China Tuberculosis Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure China Sales Market Share of Tuberculosis Drugs by Applications in 2017 Figure New Patients Picture Figure Drug Resistant TB Patients Picture Table China Market Tuberculosis Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure South China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure East China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southwest China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Northeast China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure North China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Central China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Northwest China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2023) Figure China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Tuberculosis Drugs Table Industry News List of Tuberculosis Drugs Figure Industry Chain Structure of Tuberculosis Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Tuberculosis Drugs in 2017 Figure Manufacturing Process Analysis of Tuberculosis Drugs Table Raw Materials Sources of Tuberculosis Drugs Major Manufacturers China Table Major Buyers of Tuberculosis Drugs Table Sanofi Basic Information List Table Sanofi Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Sanofi Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Sanofi Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Tuberculosis Drugs Volume in New Patients and Its Application Share Table Sanofi Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Sanofi Tuberculosis Drugs Volume in and Its Application Share Table Pfizer Basic Information List Table Pfizer Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Pfizer Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Pfizer Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Tuberculosis Drugs Volume in New Patients and Its Application Share Table Pfizer Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Pfizer Tuberculosis Drugs Volume in and Its Application Share Table Janssen Products Basic Information List Table Janssen Products Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Products Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Janssen Products Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Janssen Products Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Products Tuberculosis Drugs Volume in New Patients and Its Application Share Table Janssen Products Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Janssen Products Tuberculosis Drugs Volume in and Its Application Share Table Otsuka Basic Information List Table Otsuka Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Otsuka Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Otsuka Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Otsuka Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Otsuka Tuberculosis Drugs Volume in New Patients and Its Application Share Table Otsuka Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Otsuka Tuberculosis Drugs Volume in and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure AstraZeneca Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Tuberculosis Drugs Volume in New Patients and Its Application Share Table AstraZeneca Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table AstraZeneca Tuberculosis Drugs Volume in and Its Application Share Table Lupin Pharmaceuticals Basic Information List Table Lupin Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in New Patients and Its Application Share Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in and Its Application Share Table Akorn Basic Information List Table Akorn Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Akorn Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Akorn Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Akorn Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Akorn Tuberculosis Drugs Volume in New Patients and Its Application Share Table Akorn Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Akorn Tuberculosis Drugs Volume in and Its Application Share Table STI Pharma Basic Information List Table STI Pharma Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure STI Pharma Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure STI Pharma Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure STI Pharma Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table STI Pharma Tuberculosis Drugs Volume in New Patients and Its Application Share Table STI Pharma Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table STI Pharma Tuberculosis Drugs Volume in and Its Application Share Table Sandoz Basic Information List Table Sandoz Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sandoz Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Sandoz Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Sandoz Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sandoz Tuberculosis Drugs Volume in New Patients and Its Application Share Table Sandoz Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Sandoz Tuberculosis Drugs Volume in and Its Application Share Table Company Labatec Pharma SA Basic Information List Table Company Labatec Pharma SA Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Sales China Market Share (%) (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Revenue China Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Labatec Pharma SA Tuberculosis Drugs Volume in New Patients and Its Application Share Table Company Labatec Pharma SA Tuberculosis Drugs Volume in Drug Resistant TB Patients and Its Application Share Table Company Labatec Pharma SA Tuberculosis Drugs Volume in and Its Application Share Table China Tuberculosis Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table China Tuberculosis Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 China Tuberculosis Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 China Tuberculosis Drugs Sales Share by Players/Manufacturers Table China Tuberculosis Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table China Tuberculosis Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 China Tuberculosis Drugs Revenue Market Share (%) Players Figure 2017 China Tuberculosis Drugs Revenue Market Share (%) Players Table China Tuberculosis Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table China Tuberculosis Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Tuberculosis Drugs by Type (2012-2017) Figure China Tuberculosis Drugs Sales Growth Rate (%) by Type (2012-2017) Table China Tuberculosis Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table China Tuberculosis Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Tuberculosis Drugs by Type (2012-2017) Figure China Tuberculosis Drugs Revenue Growth Rate by Type (2012-2017) Table China Tuberculosis Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table China Tuberculosis Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Tuberculosis Drugs by Regions (2012-2017) Figure China Tuberculosis Drugs Sales Market Share by Regions in 2017 Table China Tuberculosis Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table China Tuberculosis Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Tuberculosis Drugs by Regions (2012-2017) Figure China Tuberculosis Drugs Revenue Market Share by Regions in 2017 Table China Tuberculosis Drugs Sales (K Units) and Market Share by Application (2012-2017) Table China Tuberculosis Drugs Sales Share (%) by Application (2012-2017) Figure China Tuberculosis Drugs Sales Market Share by Application (2012-2017) Figure China Tuberculosis Drugs Sales Market Share by Application (2012-2017) Figure South China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure South China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South China Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table South China Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South China Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table South China Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table South China Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South China Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure East China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure East China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure East China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table East China Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table East China Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure East China Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table East China Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table East China Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure East China Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Southwest China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southwest China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southwest China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Southwest China Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Southwest China Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Southwest China Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Southwest China Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Southwest China Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Southwest China Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Northeast China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Northeast China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast China Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Northeast China Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast China Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast China Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Northeast China Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast China Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Central China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Central China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Central China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Central China Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Central China Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Central China Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Central China Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Central China Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Central China Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure North China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure North China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure North China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table North China Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table North China Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure North China Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table North China Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table North China Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure North China Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Northwest China Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Northwest China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northwest China Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northwest China Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Northwest China Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northwest China Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Northwest China Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Northwest China Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northwest China Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure China Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Tuberculosis Drugs Price and Trend Forecast (2018-2023) Table China Tuberculosis Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure China Tuberculosis Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure China Tuberculosis Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table China Tuberculosis Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure China Tuberculosis Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure China Tuberculosis Drugs Revenue Market Share Forecast by Regions in 2023 Figure South China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure East China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure East China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure North China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Central China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Central China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table China Tuberculosis Drugs Sales (K Units) Forecast by Type (2018-2023) Figure China Tuberculosis Drugs Sales Market Share Forecast by Type (2018-2023) Table China Tuberculosis Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure China Tuberculosis Drugs Revenue Market Share Forecast by Type (2018-2023) Table China Tuberculosis Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table China Tuberculosis Drugs Sales (K Units) Forecast by Application (2018-2023) Figure China Tuberculosis Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Pfizer Janssen Products Otsuka AstraZeneca Lupin Pharmaceuticals Akorn STI Pharma Sandoz Labatec Pharma SA Archivel Farma BioMerieux Cepheid Epistem